Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Articles |
|
|
Redefining interoperability in the digital age
But as digital connectivity enables users to be more connected to their health and healthcare providers, does the old definition of interoperability still apply to today's digital world.
|
|
|
|
|
| |
|
|
|
ID determination of oligonucleotides.
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides. Oligonucleotides are oligomers which consist of few nucleotides.
|
|
|
|
Latest News & Press Releases |
|
|
UAE approves use of Sinopharm vaccine for children aged between 3 and 17 years.
The UAE announced the approval of Chinese Sinopharm COVID-19 vaccine for children aged 3-17 in the country after its efficacy in that age group...
|
|
|
|
| | |
|
| |
|
|
|
FDA Clears Vaxart's IND Application for S Only Oral Tablet COVID-19 Vaccine Candidate.
Vaxart developing oral vaccines administered by tablet, announced that the U.S. FDA has cleared Vaxart's Investigational New Drug application for an S-only...
|
|
| |
|
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets.
Glenmark and SaNOtize Research &
Development Corp. announced an exclusive long term strategic partnership to manufacture, market...
|
|
|
|
| | |
|
| |
|
|
|
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine.
Moderna announced that the U.S. FDA as granted Fast Track designation for mRNA-1345, its investigational single dose mRNA vaccine against respiratory...
|
|
|
| |
|
Vabiotech confirms production of first batch of Sputnik V vaccine in Vietnam.
Vabiotech confirmed on Wednesday the production of the first test batch of the Russian Sputnik V coronavirus vaccine at its facilities. Prior to that, the RDIF...
|
|
|
|
|
|
| |
|
|
|
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation.
Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with COVID...
|
|
|